Duration of Prophylaxis against Venous Thromboembolism with Low Molecular Weight heparin (Enoxaparin Sodium) after Major Abdominal Surgery.

Duration of Prophylaxis against Venous Thromboembolism with Low Molecular Weight heparin (Enoxaparin Sodium) after Major Abdominal Surgery. - Duration of Prophylaxis against Venous Thromboembolism with Low Molecular Weight heparin after Major Abdominal Surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007262

Enrollment

100

Registered

2012-02-11

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VTE(venous thromboembolism)

Interventions

Patients received Clexane

4,000 IU S.C. Inj. Kit (Enoxaparin Sodium) x2 daily. 1, short duration group (3days after surgery) Patients received Clexane

4,000 IU S.C. Inj. Kit (Enoxaparin Sodium) x2 daily. 2, long duration group (10days after surgery)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligible patients were 40 years of age or older, and were scheduled to undergo surgery for a malignant tumor of the gastrointestinal tract.

Exclusion criteria

Exclusion criteria: severe renal insufficiency known hypersensitivity to Enoxaparin Sodium treatment with anticoagulant therapy before surgery generalized bleeding disorder

Design outcomes

Primary

Measure	Time frame
Patients were randomly assigned to receive Low Molecular Weight heparin (Enoxaparin Sodium) for 3days or 10days. Venous ultrasonography was performed after 11days. The end point to with respect to efficacy was the incidence of venous thromboembolism.	—

Countries

Japan

Contacts

Public ContactShunsaku Katsura

Yamaguchi University Graduate School of Medicine Department of Surgery and Clinical Science

shunsaku@yamaguchi-u.ac.jp0836-22-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026